Skip to main
GHK-Cu Prescribed

A hand-set kitchen-table reading of the copper-tripeptide literature — every collagen study, gene-expression map, and hair-follicle trial plated like a family recipe and sourced to the paper it came from.

Study 02

What GHK-Cu animal amounts cannot settle for people

Skin-product trials measured wrinkles or counted hairs in people. Most injection experiments used animals. Human shot benefits, safe amounts and risks remain unsettled for you.

What GHK-Cu amounts belonged to each experiment

People had skin and hair changes in cream and mixed-spray trials. Rats and mice received most of the tested injections. Human trials haven't established a GHK-Cu shot amount that is safe and useful. Animal amounts varied with body weight, illness and the way treatment entered the body, so comparing amounts from different experiments cannot establish what you would receive or whether that amount helps.

An animal's weight doesn't give you a safe human amount.

Some shots beneath animals' skin used up to 20 milligrams for every kilogram the animal weighed. Heavier animals received more GHK-Cu. Human creams contained 1–3% GHK-Cu; the remaining ingredients made up the rest.

These are descriptions of experiments, without instructions for your treatment.

  • Lung injury in mice: Smoke tests ran for 12 weeks. Daily amounts included 2 and 20 micrograms of GHK-Cu per gram of a mouse's weight [15]. Sudden-injury tests used 1 and 10 micrograms per gram [5]. Micrograms weigh millionths of one gram. In a lung-scarring test, belly shots were given on alternate days during days 4–21 [6]. The paper lists 26 and 260 micrograms per milliliter of liquid. The paper says “per day” without clearly stating each shot's total amount.
  • Memory in mice: the old mice received daily nose treatment for 8 weeks [19]. The amount was 15 milligrams of GHK-Cu per kilogram of mouse weight. The mice with Alzheimer's-like disease received 15 milligrams per kilogram three times weekly for 12 weeks [17].
  • Collagen in dishes: the greatest collagen increase in human skin cells came with 1 nanomolar GHK-Cu, a trace of GHK-Cu mixed into liquid [1]. This was weaker than the micromolar mixtures tested for skin-cell growth.
  • Skin and hair in people: creams contained 1–3% GHK-Cu. A 6-month trial tested a spray named ALAVAX [11]. The spray had GHK without attached copper and a second ingredient tested for hair growth. Its strengths, 50 or 100 milligrams per milliliter, measured the whole mixture rather than GHK-Cu alone.
  • An untested estimate: Pickart suggested 100–200 milligrams in total. The estimate didn't clearly state who would receive that amount or over how long. No trial checked the estimate.

You can't turn that guess into a tested treatment.

What GHK-Cu skin tests measured instead of injection timing

Copper passed through donated human skin in a 2010 experiment [14]. The skin came from people who had died. Researchers tested 1 square centimeter over 48 hours. A square centimeter covers less than a fingertip. For each square centimeter, the skin retained 97 micrograms of copper. Micrograms weigh millionths of one gram. Researchers thought applying GHK-Cu to skin might deliver copper to nearby tissue.

No living person's benefit or harm was tested.

No human test has timed how quickly injected GHK-Cu leaves blood. Natural GHK, the protein part that can carry copper, was measured separately. Blood levels in people's 20s were about 200 billionths of a gram of GHK per milliliter. In their 60s, levels were near 80 billionths of a gram of GHK per milliliter [16]. Both amounts are tiny traces; each milliliter is less blood than a teaspoon holds.

Those age comparisons didn't follow an injection through your body.

Water dissolves GHK-Cu readily, while skin's oily surface makes entry harder. Lab mixtures stayed intact for two or more weeks at 60 degrees C. Powder was kept long term at -20 degrees C, below freezing. Liquid was kept briefly at 4 degrees C, around refrigerator temperature.

A compound staying intact doesn't establish that treatment is safe.

Mouse nose tests found brain changes with 15 milligrams of GHK-Cu per kilogram of mouse weight [17][19]. The brain has a barrier that keeps many substances out. These findings suggest nose treatment got past that barrier in mice. No human trial has measured how much GHK-Cu enters blood or brain after nose treatment.

Why GHK-Cu skin-product findings cannot answer shot questions

Women had shallower wrinkles and less loose skin after cream treatment. Two 12-week trials involved 41 and 71 women [7]. A 6-month mixed-spray trial found more scalp hairs [11]. Another test measured copper crossing donated human skin [14].

You have some results for skin products; injections remain untested in people.

GHK-Cu dissolves readily in water. Skin's oily outer layer makes entry harder. In 2025, researchers put GHK-Cu inside tiny shells made from fat [23]. They hoped those shells would carry more through skin. During preparation, 20–32% of the supplied GHK-Cu went inside the shells.

That measures successful filling of shells, without measuring entry into skin.

Injection tests mostly used animals, including mice with injured lungs. Memory tests delivered treatment through mice's noses. Neither followed an injection through a person's blood and tissue. People need to be tested to learn where GHK-Cu goes after a shot, whether skin improves, and whether people face different harms than they did with cream.

What GHK-Cu temperature tests reveal about breakdown

A lab mixture stayed intact during two weeks at 60 degrees C [23]. That temperature is well above hot bath water. Researchers checked breakdown of GHK-Cu, without testing whether treatment was safe.

Your shot safety can't be established by a storage test.

Lab staff dissolved powder in water containing an ingredient that slows bacterial growth. Reports describe powder kept at -20 degrees C, below freezing. Liquid was kept briefly at 4 degrees C, around refrigerator temperature. Those are lab conditions; the tests didn't establish safe preparation of treatment at home.

What GHK-Cu research lacks about breaks and restarts

Animal treatment continued for 4–12 weeks without planned breaks. Researchers didn't test whether stopping and restarting improved people's results. Continued use in animals hasn't established safe continued use for you.

Some people try GHK-Cu on themselves as research and describe breaks online. These are personal accounts, without an untreated group for comparison. No trial has checked whether their reported breaks change benefit or harm.

The sudden lung-injury tests lasted 8 days [5]. Emphysema and Alzheimer's-like mouse tests lasted 12 weeks [15][17]. Treatment was daily or on alternate days. The experiments didn't pause until GHK-Cu had left the body before starting again.

You still lack tests of whether breaks help or restarting is safe.

Researchers haven't clearly shown GHK-Cu losing its effect during continued treatment, and they haven't shown that a break brings benefit back, so neither claim can guide your decision about stopping or restarting. Long animal tests of repeated stops and restarts haven't appeared. These unanswered questions leave safety over time unsettled.

What GHK-Cu short trials reported, and what harm remains untested

Few problems were reported in the two 12-week cream trials [7]. The 6-month mixed scalp-spray trial also reported little harm [11]. Neither spray strength had reported side effects.

Brief skin-product use can't establish years of shot safety for you.

Research papers raise a possible concern about copper buildup during prolonged treatment. Your body needs traces of copper. Too much can damage the liver and nerves. Human injection studies haven't measured that possible risk or established safety over years, so a brief cream trial can't answer your question about copper buildup after repeated treatment throughout the body.

In Min's 2024 experiment, GHK reduced copper damage to nerve cells [20]. GHK is the protein part without copper attached. It helped cells resist harmful chemical reactions and protein clumps. Cells supporting nerves survived better too. Researchers grew these cells in a lab; nobody received treatment.

Cell survival doesn't prove that shots protect your nerves.

Large human trials haven't established benefits throughout the body. Safe shot amounts remain unsettled, and no human study has followed injected GHK-Cu through tissue.

Some cream ingredients can hold copper more firmly than GHK does. Strong vitamin C mixtures may loosen the bond between GHK and copper. That could affect how skin cells use the copper. This concern is about ingredients together in a skin product. An ordinary vitamin tablet swallowed separately wasn't the treatment being discussed.

You still lack human comparisons establishing the effects of these skin mixtures. Researchers also haven't tested the benefits or harm of combining GHK-Cu with other treatments.